Cargando…

Fear of cancer recurrence and PSA anxiety in patients with prostate cancer: a systematic review

PURPOSE: The impact of prostate cancer on the mental wellbeing of patients is increasingly being appreciated. Two important aspects of this include fear of cancer recurrence (FCR) and prostate-specific antigen (PSA) anxiety. However, their prevalence, severity and associating factors remain poorly u...

Descripción completa

Detalles Bibliográficos
Autores principales:	James, Callum, Brunckhorst, Oliver, Eymech, Omar, Stewart, Robert, Dasgupta, Prokar, Ahmed, Kamran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135793/ https://www.ncbi.nlm.nih.gov/pubmed/35106656 http://dx.doi.org/10.1007/s00520-022-06876-z

Ejemplares similares

An exploration of wellbeing in men diagnosed with prostate cancer undergoing active surveillance: a qualitative study
por: Eymech, Omar, et al.
Publicado: (2022)

Body image, self-esteem, and sense of masculinity in patients with prostate cancer: a qualitative meta-synthesis
por: Bowie, Jessica, et al.
Publicado: (2021)

Undergoing radical treatment for prostate cancer and its impact on wellbeing: A qualitative study exploring men’s experiences
por: Vyas, Neel, et al.
Publicado: (2022)

Mental wellbeing and quality of life in prostate cancer (MIND-P): Protocol for a multi-institutional prospective cohort study
por: Brunckhorst, Oliver, et al.
Publicado: (2023)

Non-technical skills: a review of training and evaluation in urology
por: Griffin, Cora, et al.
Publicado: (2019)

Erectile dysfunction in patients with anxiety disorders: a systematic review
por: Velurajah, Rajalaxmi, et al.
Publicado: (2021)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer
por: Paller, CJ, et al.
Publicado: (2013)

Redo-urethroplasty for the management of recurrent urethral strictures in males: a systematic review
por: Jasionowska, Sara, et al.
Publicado: (2019)

Editorial: Uncertainty, Anxiety, and Fear of Cancer Recurrence
por: Butow, Phyllis, et al.
Publicado: (2021)

A simple computer program for calculating PSA recurrence in prostate cancer patients
por: Liao, Zhongyue, et al.
Publicado: (2004)

Analysis of monotherapy prostate brachytherapy in patients with prostate cancer. Initial PSA and Gleason are important for recurrence?
por: Galego, Pedro, et al.
Publicado: (2015)

Competitive Inoculation as an Effective Prophylaxis Against Recurrent Urinary Tract Infections: A Systematic Review
por: Mak, Quentin, et al.
Publicado: (2023)

Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review
por: Koo, Kyo Chul, et al.
Publicado: (2018)

The Role of Augmented Reality in Surgical Training: A Systematic Review
por: Suresh, Dhivya, et al.
Publicado: (2022)

Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence
por: Truong, M, et al.
Publicado: (2012)

High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer
por: JACOBSEN, FRANK, et al.
Publicado: (2013)

Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade
por: Venkatesan, Aradhana M., et al.
Publicado: (2021)

Contemporary Management of Chronic Prostatitis
por: Khattak, Ahmed S, et al.
Publicado: (2021)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
por: Strittmatter, F, et al.
Publicado: (2011)

Metastatic prostate cancer in the modern era of PSA screening
por: Fontenot, Philip A., et al.
Publicado: (2017)

Using a Recurrent Neural Network To Inform the Use of Prostate-specific Antigen (PSA) and PSA Density for Dynamic Monitoring of the Risk of Prostate Cancer Progression on Active Surveillance
por: Sushentsev, Nikita, et al.
Publicado: (2023)

PSA and PSA Kinetics Thresholds for the Presence of (68)Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer
por: Hoffmann, Manuela Andrea, et al.
Publicado: (2020)

High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer
por: Heumann, Asmus, et al.
Publicado: (2018)

PSCA expression is associated with favorable tumor features and reduced PSA recurrence in operated prostate cancer
por: Heinrich, Marie-Christine, et al.
Publicado: (2018)

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer
por: von Eyben, Rie, et al.
Publicado: (2023)

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
por: Tomioka, Atsushi, et al.
Publicado: (2014)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

A comparative analysis of single port versus multi-port robotic assisted radical prostatectomy for prostate cancer
por: Walsh, Anna L, et al.
Publicado: (2020)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
por: Chang, Tsung-Hsin, et al.
Publicado: (2020)

Characterisation of the main PSA glycoforms in aggressive prostate cancer
por: Gratacós-Mulleras, Anna, et al.
Publicado: (2020)

Genetically adjusted PSA levels for prostate cancer screening
por: Kachuri, Linda, et al.
Publicado: (2023)

A Systematic Review of Simulation-Based Training in Vascular Surgery
por: Haiser, Alexander, et al.
Publicado: (2022)

Exploration of the Value of Combined UA, IL-6, and fPSA/tPSA in the Diagnosis of Prostate Cancer
por: Tang, Qionghua, et al.
Publicado: (2022)

Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer
por: Cho, Hyungseok, et al.
Publicado: (2022)

Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer
por: Foekens, J A, et al.
Publicado: (1999)

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
por: Burdelski, Christoph, et al.
Publicado: (2015)

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
por: Zabalza, Cristina Villares, et al.
Publicado: (2015)

Overexpression of thymidylate synthase (TYMS) is associated with aggressive tumor features and early PSA recurrence in prostate cancer
por: Burdelski, Christoph, et al.
Publicado: (2015)

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
por: Ishikawa, Hitoshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ilr360u8rj4mt4tfmgor2q45do